Status:
UNKNOWN
Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery
Lead Sponsor:
Second Military Medical University
Conditions:
Diabetic Macular Edema
Cataract
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The investigators aim to evaluate how different timing of anti-VEGF intravitreous injections affect visual acuity (BCVA) in patients with diabetic macular edema who are undergoing cataract surgery; an...
Detailed Description
Cataract is very common in diabetic patients and can lead to significant vision loss and disability without medical intervention. Diabetic patients, particularly those with diabetic macular edema (DME...
Eligibility Criteria
Inclusion
- Adults over age 18 with diabetes mellitus, diabetic macular edema and visually significant cataracts planning to undergo cataract surgery
Exclusion
- Patients who have undergone panretinal photocoagulation (PRP) in prior 4 months or an ocular condition (other than cataract and DME) that might affect visual acuity during course of study.
- Patients with history of vitrectomy. Patients with neovascular glaucoma
Key Trial Info
Start Date :
August 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04063358
Start Date
August 22 2019
End Date
August 31 2021
Last Update
March 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, Shanghai Municipality, China, 86-21